Vudalimab Biosimilar - Research Grade

Vudalimab Biosimilar - Research Grade, Human IgG1(N208D/E233P/L234V/L235A/G236Del/S267K/Q295E/L368D/K370S/N384D/Q418E/N421D/M428L/N434S)-Kappa

Target: PD-1 x CTLA-4.

Specificity: Detects human PD-1 and human CTLA-4.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Uses the same sequence as the therapeutic antibody Vudalimab.

Concentration: 5mg/ml.

Formulation: 20mM His/Asp, pH 5.0,Contains no stabilizers or preservatives.

Purity: ≥95% monomer by analytical SEC, >95% by SDS Page.

Endotoxin: <1EU/mg Determined by LAL gel clotting assay.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.

• Artikelnummer: ICH5113-10MG
• Hersteller: Ichorbio
• Hersteller Artikelnummer: ICH5113-10MG
• Verpackungseinheit: 10mg
• Mengeneinheit: STK
• Reaktivität: Human
• Klonalität: Monoclonal
• Methode: Functional Assay
• Isotyp: Human IgG1(N208D/E233P/L234V/L235A/G236Del/S267K/Q295E/L368D/K370S/N384D/Q418E/N421D/M428L/N434S)-Kappa